Bionik Laboratories Past Earnings Performance
Past criteria checks 0/6
Bionik Laboratories has been growing earnings at an average annual rate of 8.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 11.3% per year.
Key information
8.5%
Earnings growth rate
48.8%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | -11.3% |
Return on equity | n/a |
Net Margin | -274.0% |
Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bionik Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 23 | 2 | -5 | 5 | 1 |
31 Dec 22 | 1 | -5 | 5 | 1 |
30 Sep 22 | 1 | -11 | 5 | 1 |
30 Jun 22 | 1 | -11 | 5 | 1 |
31 Mar 22 | 1 | -10 | 5 | 1 |
31 Dec 21 | 2 | -10 | 5 | 1 |
30 Sep 21 | 2 | -12 | 5 | 1 |
30 Jun 21 | 2 | -12 | 5 | 1 |
31 Mar 21 | 1 | -14 | 6 | 2 |
31 Dec 20 | 2 | -29 | 7 | 2 |
30 Sep 20 | 2 | -23 | 8 | 3 |
30 Jun 20 | 2 | -25 | 9 | 3 |
31 Mar 20 | 2 | -25 | 9 | 4 |
31 Dec 19 | 2 | -12 | 8 | 4 |
30 Sep 19 | 3 | -11 | 8 | 4 |
30 Jun 19 | 4 | -12 | 7 | 3 |
31 Mar 19 | 3 | -11 | 8 | 3 |
31 Dec 18 | 2 | -13 | 7 | 3 |
30 Sep 18 | 2 | -14 | 7 | 3 |
30 Jun 18 | 1 | -13 | 8 | 3 |
31 Mar 18 | 1 | -15 | 7 | 3 |
31 Dec 17 | 1 | -12 | 7 | 3 |
30 Sep 17 | 1 | -11 | 7 | 3 |
30 Jun 17 | 0 | -8 | 5 | 3 |
31 Mar 17 | 1 | -8 | 6 | 3 |
31 Dec 16 | 1 | -14 | 6 | 1 |
30 Sep 16 | 0 | -3 | 6 | 1 |
30 Jun 16 | 0 | 0 | 5 | 1 |
31 Mar 16 | 0 | -7 | 5 | 1 |
31 Dec 15 | 0 | -6 | 4 | 1 |
30 Sep 15 | 0 | -7 | 3 | 2 |
30 Jun 15 | 0 | -11 | 3 | 2 |
31 Mar 15 | 0 | -10 | 2 | 2 |
31 Dec 14 | 0 | -3 | 2 | 1 |
31 Mar 14 | 0 | -1 | 1 | 1 |
Quality Earnings: BNKL is currently unprofitable.
Growing Profit Margin: BNKL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BNKL is unprofitable, but has reduced losses over the past 5 years at a rate of 8.5% per year.
Accelerating Growth: Unable to compare BNKL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BNKL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.7%).
Return on Equity
High ROE: BNKL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.